GABAA receptor positive allosteric modulators modify the abuse-related behavioral and neurochemical effects of methamphetamine in rhesus monkeys

Neuropharmacology
Laís F BerroLeonard L Howell

Abstract

GABAA receptor positive allosteric modulators (GABAA receptor modulators) are commonly used for the treatment of insomnia. Nevertheless, the effects of these compounds on psychostimulant-induced sleep impairment are poorly understood. Because GABAA receptor modulators have been shown to decrease the abuse-related effects of psychostimulants, the aim of the present study was to evaluate the effects of temazepam (0.3, 1.0 or 3.0 mg/kg) and eszopiclone (0.3, 1.0 or 3.0 mg/kg), two GABAA receptor modulators, on the behavioral neuropharmacology of methamphetamine in adult rhesus macaques (n = 5). Sleep-like measures and general daytime activity were evaluated with Actiwatch monitors. Methamphetamine self-administration (0.03 mg/kg/inf) was evaluated during morning sessions. Methamphetamine-induced dopamine overflow was assessed through in vivo microdialysis targeting the nucleus accumbens. Nighttime treatment with either temazepam or eszopiclone was ineffective in improving sleep-like measures disrupted by methamphetamine self-administration. Acute pretreatment with a low dose of temazepam before self-administration sessions increased methamphetamine self-administration without affecting normal daytime home-cage activity. At a high ...Continue Reading

References

Sep 2, 1998·Synapse·S L DeweyJ D Brodie
Nov 1, 1991·Behavioural Pharmacology·J.P. DruhanA.G. Phillips
Jul 3, 2004·Journal of Clinical Psychopharmacology·Craig R RushPaul E A Glaser
Jul 12, 2005·Drug and Alcohol Dependence·Elise M WeertsRoland R Griffiths
Jul 22, 2005·The Journal of Pharmacology and Experimental Therapeutics·Andrew C BarrettS Barak Caine
Mar 7, 2006·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·Russell P Rosenberg
Feb 26, 2008·Pharmacology, Biochemistry, and Behavior·Stephanie C Licata, James K Rowlett
Dec 24, 2008·The Journal of Pharmacology and Experimental Therapeutics·Rajkumar J SevakCraig R Rush
May 12, 2009·Addiction·Christopher C Cruickshank, Kyle R Dyer
Nov 28, 2009·Journal of Psychopharmacology·David J Nutt, S M Stahl
Feb 12, 2010·Nature·Arthur C Riegel, Peter W Kalivas
Apr 9, 2010·Alcoholism, Clinical and Experimental Research·Maria M WongRobert A Zucker
Apr 14, 2010·Psychopharmacology·Monica L AndersenLeonard L Howell
May 15, 2010·The Journal of Pharmacology and Experimental Therapeutics·K S MurnaneL L Howell
Mar 1, 2011·Trends in Neurosciences·Kelly R TanChristian Lüscher
May 17, 2011·Drugs of Today·R T Owen
Oct 12, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Michel BarrotThomas C Jhou
Feb 1, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Maria BorisovskaGary L Westbrook
Feb 14, 2013·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Naren Gunja
Aug 16, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kevin S MurnaneLeonard L Howell
Oct 29, 2013·Annual Review of Pharmacology and Toxicology·Uwe Rudolph, Hanns Möhler
Feb 6, 2014·Sleep·Suzanne M BertischCatherine Buettner
Aug 20, 2014·Current Psychiatry Reports·Deirdre A Conroy, J Todd Arnedt
Nov 22, 2014·Journal of Addictive Diseases·Diane M HerbeckKatherine Lovinger
Dec 17, 2014·Pharmacological Reviews·Leonard L Howell, Kathryn A Cunningham
Mar 31, 2015·British Journal of Pharmacology·Christine L DixonAngelo Keramidas
Apr 22, 2015·Lancet Neurology·Dieter RiemannKai Spiegelhalder
Jun 13, 2015·American Journal of Public Health·Ryan N HansenSean D Sullivan
Feb 18, 2016·Experimental and Clinical Psychopharmacology·Laís F BerroLeonard L Howell
Aug 4, 2016·Drug and Alcohol Dependence·Allyson L SpenceNicholas E Goeders
Oct 19, 2016·Clinical Therapeutics·Jennifer L SchroeckKari A Mergenhagen
Dec 18, 2016·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Maylen Perez DiazLeonard L Howell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.